Journal
CELLULAR SIGNALLING
Volume 18, Issue 10, Pages 1793-1800Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2006.02.002
Keywords
5-HT2A receptor; NPxxY; DPxxY; ARF; phospholipase D; PLD
Categories
Funding
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
in this study we have shown that N376 to D mutation in the conserved NPxxY motif within the carboxy terminal tail domain (CT) of the 5-HT2A receptor alters the binding preference of GST-fusion protein constructs of the CT domain from ARF1 to an alternative isoform, ARF6. These findings were corroborated by experiments investigating co-immunoprecipitation of the wild type (WT) and N376D mutant of the 5-HT2A receptor with ARF1 or 6 or dominant negative ARFI/6 constructs co-expressed in COS7 cells. In functional assays of 5-HT-induced phospholipase D (PLD) activation responses of the WT receptor were inhibited by a dominant negative mutant of ARF1 but not ARF6, whereas responses of the N376D mutant were strongly inhibited by negative mutant ARF6. No equivalent effect of the ARF mutants was seen on phospholipase C activation. In experiments assaying 5-HT-induced increases in [S-35]GTP-gamma S binding to ARF 1/6 immumoprecipitates as a measure of ARF activation, increased ARF6 activation was seen only with the mutant receptor. When cellular PLD responses of other NPxxY- or a DPxxY-containing GPCRs were measured in the presence of dominant negative ARFI/6 constructs, the majority, but not all, fitted the pattern exemplified by the 5-HT2A receptor and its N376D mutant. These data suggest that the presence of the NPxxY or a D in this highly conserved motif is an important, but not exclusive, determinant of which ARF isoform interacts with the GPCR. (c) 2006 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available